Ramipril
Links shared publicly online about this topic
Ramipril on #MDlinx
mdlinx.com — “Ramipril on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 27, 2010 at 11:09 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Effects of ethnicity on diabetes incidence and prevention: results of the Diabetes REduction Assessment with ... http://bit.ly/aforeU #endo
Endocrinology Article | Ramipril
mdlinx.com — “Incidence of Diabetes Following Ramipril or Rosiglitazone Withdrawal” View full resource at mdlinx.com
Most Recently Shared on May 3, 2011 at 4:05 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Incidence of Diabetes Following Ramipril or Rosiglitazone Withdrawal: Diabetes Care http://bit.ly/jwuimV #endo
Family Medicine Article | Ramipril
mdlinx.com — “Incidence of Diabetes Following Ramipril or Rosiglitazone Withdrawal” View full resource at mdlinx.com
Most Recently Shared on May 4, 2011 at 4:09 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Incidence of Diabetes Following Ramipril or Rosiglitazone Withdrawal: Diabetes Care http://bit.ly/jCPVC1 #FamPractice
Endocrinology Article | Ramipril
mdlinx.com — “Long-term effect of rosiglitazone and/or ramipril on the incidence of diabetes” View full resource at mdlinx.com
Most Recently Shared on December 6, 2010 at 1:17 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Long-term effect of rosiglitazone and/or ramipril on the incidence of diabetes: Diabetologia - Clinical an... http://bit.ly/i6Pn7H #endo
Ramipril Improves Walking in Claudicants in RCT : Internal Medicine News
internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice tre” View full resource at internalmedicinenews.com
Most Recently Shared on November 18, 2011 at 4:52 pm By:
Bob Finn - Medical News Net Health News
Study: ACE inhibitor ramipril boosted walking ability, quality of life in patients with peripheral arterial disease http://t.co/4asOQuBw
Cardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal Risk
instapaper.com — “Cardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal Risk” View full resource at instapaper.com
Most Recently Shared on March 2, 2011 at 4:37 pm By:
Yvo Sijpkens MD Nephrologist, Physician, Doctor, and Internist
No support for dual RAS-blocking therapy over monotherapy in high–risk patients with low eGFR or albuminuria: http://bit.ly/gRG0xt
The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial - Full Text View - ClinicalTrials.gov
clinicaltrials.gov — “The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial - Full Text View - ClinicalTrials.gov” View full resource at clinicaltrials.gov
Most Recently Shared on April 27, 2011 at 9:40 pm By:
Ivan Oransky Health Communicator and Doctor
Of course, as soon as I tweet about a good clinical trial acronym, I come across the DREAM study http://1.usa.gov/iJSpue My nightmare!
Ramipril retards development of aortic valve stenosis in a rabbit model: mechanistic considerations - Ngo - British Journal of Pharmacology - Wiley Online Library
onlinelibrary.wiley.com — “Ramipril retards development of aortic valve stenosis in a rabbit model: mechanistic considerations - Ngo - British Journal of Pharmacology - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on October 20, 2010 at 4:07 pm By:
Drugs and Devices OW OW Health
Ramipril retards development of aortic valve stenosis in a rabbit model: mechanistic considerations: Summary (Sour... http://bit.ly/bIjjtj
Rosuvastatin combined with ramipril significantly reduced atheroma volume by anti-inflammatory mechanism: Comparative analysis with rosuvastatin alone by intravascular ultrasound
ntkinstitute.org — “Rosuvastatin combined with ramipril significantly reduced atheroma volume by anti-inflammatory mechanism: Comparative analysis with rosuvastatin alone by intravascular ultrasound” View full resource at ntkinstitute.org
Most Recently Shared on March 8, 2011 at 12:31 pm By:
James Underberg Internist, Physician, and Doctor
#Rosuvastatin & #ramipril significantly reduced atheroma volume as compared to Rosuva by intravascular ultrasound http://goo.gl/8OLLK
Cardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal Risk: Results From the ONTARGET and TRANSCEND Studies -- Tobe et al., 10.1161/CIRCULATIONAHA.110.964171 -- Circulation
circ.ahajournals.org — “Cardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal Risk: Results From the ONTARGET and TRANSCEND Studies -- Tobe et al., 10.1161/CIRCULATIONAHA.110.964171 -- Circulation” View full resource at circ.ahajournals.org
Most Recently Shared on March 1, 2011 at 4:00 pm By:
James Underberg Internist, Physician, and Doctor
http://bit.ly/frxYdt CV& Renal Outcomes With Telmisartan & or Ramipril in High Renal Risk:From ONTARGET& TRANSCEND-no benefit of dual Rx
Rasilez, first-in-class direct renin inhibitor, provides greater reduction in high blood pressure than ACE inhibitor ramipril in patients 65 and older
novartis.com — “Basel, November 11, 2008 - New clinical data presented today show first-in-class direct renin inhibitor Rasilez [*] (aliskiren), known as Tekturna in the US, provides significantly greater blood pressure reductions in patients with high blood pressure aged 65 and over, compared to the angiotensin-converting enzyme (ACE) inhibitor ramipril[1].” View full resource at novartis.com
Most Recently Shared on November 11, 2008 at 6:19 pm By:
Rasilez®, first-in-class direct renin inhibitor, provides greater reduction in high blood pressure than .. http://tinyurl.com/66erzc
Drug interactions of Spironolactone, Terazosin Hcl, Ramipril, Multi-vitamin, Lasix, Carvedilol, Lipitor, Aspirin, Coumadin, Digoxin, include Thrombocytopenia, Therapeutic Agent Toxicity, Pain, Nausea, Hypotension, Emotional Disorder, Economic Problem, Dys
ehealthme.com — “Real world drug outcomes: Drug interactions of Spironolactone, Terazosin Hcl, Ramipril, Multi-vitamin, Lasix, Carvedilol, Lipitor, Aspirin, Coumadin, Digoxin, include Thrombocytopenia, Therapeutic Agent Toxicity, Pain, Nausea, Hypotension, Emotional Disorder, Economic Problem, Dyspnoea, Bradyarrhythmia, Atrial Fibrillation, Arthralgia, Anorexia, and long term effects (ID: 2897851)” View full resource at ehealthme.com
Most Recently Shared on September 6, 2009 at 9:24 pm By:
Drug interactions analysis of Spironolactone, Terazosin Hcl ... http://bit.ly/2lC97P
Drug interactions of Celebrex, Celexa, Wellbutrin Sr, Crestor, Ramipril, Metoprolol Tartrate for a female aged 57 who has Inflammation Localised, Depression, Blood Cholesterol Increased, Blood Pressure Management, long term effects included (ID: 2974316)
ehealthme.com — “Real world drug outcomes: Drug interactions of Celebrex, Celexa, Wellbutrin Sr, Crestor, Ramipril, Metoprolol Tartrate for a female aged 57 who has Inflammation Localised, Depression, Blood Cholesterol Increased, Blood Pressure Management, long term effects included (ID: 2974316)” View full resource at ehealthme.com
Most Recently Shared on November 1, 2009 at 9:06 pm By:
Drug interactions of Celebrex, Celexa, Wellbutrin Sr, Crestor ... http://bit.ly/3Th87r
FDA panel reviews telmisartan
theheart.org — “UPDATED // The panel grappled with noninferiority margins and other statistical issues during the daylong hearing, and while it wouldn't give a wide indication for use in all high-risk cardiovascular patients, it felt that telmisartan is a good option for patients intolerant to the ACE inhibitor ramipril.” View full resource at theheart.org
Most Recently Shared on July 29, 2009 at 9:39 pm By:
heartwire: No to expanded indication for telmisartan, except in ramipril-intolerant patients, says FDA.. http://bit.ly/HGHJa
Kidney Transplant Medications
muschealth.com — “Kidney Transplant Medications: Using ramipril to control protein in urine - MUSC - Learn more about kidney transplant medications and ramipril in this health podcast” View full resource at muschealth.com
Most Recently Shared on October 26, 2009 at 3:53 pm By:
Kidney Transplant Medications: Using ramipril to control protein in urine http://tinyurl.com/ykpmh3c
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
